![Seth Rudnick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seth Rudnick
Founder at
Altesa Biosciences, Inc.
Profile
Seth A. Rudnick was the founder of Ortho Biotech, Inc., founded in 1986, where the title held was Head-Research & Development from 1986 to 1991.
Dr. Rudnick is also the founder of Altesa BioSciences, Inc...
Current jobs include Chairman at Liquidia Technologies, Inc. since 2008; Director at Artizan Biosciences, Inc.; Venture Partner at Pitango Venture Capital; Clinical Professor-Medicine at The University of North Carolina at Chapel Hill; Clinical Professor at The University of North Carolina at Charlotte; and Advisor at HighCape Capital Acquisition Corp.
II since 2014.
Former jobs include Chairman & Chief Executive Officer at CytoTherapuetics, Inc. from 1991 to 1998; Chairman at Orthocon, Inc. from 2006 to 2014; Chairman at Meryx, Inc.; Director at Genaissance Pharmaceuticals, Inc.; Independent Director at POZEN, Inc. from 2011 to 2016; Director at Immunicon Corp.; Director at Cylex, Inc.; Director at Sopherion Therapeutics LLC; Director at CombinatoRx, Inc.; Independent Director at Square 1 Financial, Inc. from 2012 to 2015; Director at Adlyfe, Inc.; Director at Lq3 Pharmaceuticals, Inc.; Director at Spine Wave, Inc.; Director at VaxInnate Corp.; Director at Square 1 Bank; Independent Director at G1 Therapeutics, Inc. from 2019 to 2021; Director at Abyrx, Inc.; Director at Envisia Therapeutics, Inc.; Independent Director at Old API Wind-down Ltd. from 2011 to 2018; Independent Director at Liquidia Corp.
in 2020; Head-Pharmaceutical Development at Biogen, Inc. from 1982 to 1986; Advisor at Connecticut Innovations, Inc.; General Partner at Chimerix, Inc. in 2010; General Partner at Canaan Management, Inc. from 1998 to 2010; Principal at Schering-Plough Animal Health Corp.; and Advisor at HighCape Capital Acquisition Corp.
Education includes a doctorate degree from the University of Virginia conferred in 1974 and an undergraduate degree from the University of Pennsylvania conferred in 1969.
Seth Rudnick active positions
| Companies | Position | Start |
|---|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Chairman | 01/01/2008 |
Artizan Biosciences, Inc.
 Artizan Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapies for the diseases that involve the human intestinal microbiotas | Director/Board Member | - |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
HighCape Capital Acquisition Corp. II
 HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Corporate Officer/Principal | 01/01/2014 |
Altesa Biosciences, Inc.
 Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Founder | - |
Pitango Venture Capital
 Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital invests in companies located in Israel. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Private Equity Investor | - |
Former positions of Seth Rudnick
| Companies | Position | End |
|---|---|---|
| G1 THERAPEUTICS, INC. | Chairman | 12/06/2019 |
| LIQUIDIA CORPORATION | Director/Board Member | 28/12/2020 |
| ░░░ ░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Seth Rudnick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
36
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 36 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Connecticut Innovations, Inc.
 Connecticut Innovations, Inc. Investment ManagersFinance CI invests in companies located in the US, primarily in Connecticut. The firm targets companies operating in the fields of Greentech, Consumer, Healthcare, Venture Funds, Technology. It provides debt and equity financing for seed and early stage capital requirements with an investment size up to $500,000. | Finance |
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and uses genetic information to diagnostic and therapeutic products | Health Technology |
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops therapeutics for diseases | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Immunicon Corp.
 Immunicon Corp. Medical SpecialtiesHealth Technology Develops cell-based research and diagnostic products | Health Technology |
Cylex, Inc.
 Cylex, Inc. Medical SpecialtiesHealth Technology Manufactures and develops patented in vitro diagnostic products | Health Technology |
Sopherion Therapeutics LLC
 Sopherion Therapeutics LLC BiotechnologyHealth Technology Develops and commercializes anti-cancer therapies | Health Technology |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Ortho Biotech, Inc. | |
Square 1 Financial, Inc.
 Square 1 Financial, Inc. Regional BanksFinance Operates as a bank holding company which provides banking services | Finance |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Adlyfe, Inc.
 Adlyfe, Inc. Medical DistributorsDistribution Services Develops diagnostic products | Distribution Services |
Lq3 Pharmaceuticals, Inc.
 Lq3 Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops innovative oral health therapies | Health Services |
Canaan Management, Inc.
 Canaan Management, Inc. Investment ManagersFinance Canaan Management invests in companies located in the United States. The firm focuses on companies such as consumer, fintech, enterprise/cloud, biopharmaceuticals, medical technology and digital health. It participates in early-stage capital requirements. | Finance |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schering-Plough Animal Health Corp.
 Schering-Plough Animal Health Corp. Pharmaceuticals: MajorHealth Technology Develops and manufatures pharmaceutical and biological products for food producing animals | Health Technology |
Spine Wave, Inc.
 Spine Wave, Inc. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of spinal disorders | Health Technology |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital invests in companies located in Israel. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Finance |
CytoTherapuetics, Inc.
 CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Finance |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases | Health Technology |
Orthocon, Inc.
 Orthocon, Inc. Medical SpecialtiesHealth Technology Designs, develops, and markets medical implantable devices | Health Technology |
Square 1 Bank
 Square 1 Bank Regional BanksFinance State chartered commercial bank | Finance |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Abyrx, Inc.
 Abyrx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical therapeutic devices | Health Technology |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel ocular therapies | Health Technology |
Meryx, Inc.
 Meryx, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Health Technology |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Artizan Biosciences, Inc.
Artizan Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapies for the diseases that involve the human intestinal microbiotas | Health Technology |
HighCape Capital Acquisition Corp.
 HighCape Capital Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
HighCape Capital Acquisition Corp. II
HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Health Technology |
- Stock Market
- Insiders
- Seth Rudnick
